EX-32.2 6 f10k2023a1ex32-2_inmedphar.htm CERTIFICATION

Exhibit 32.2


Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002


Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Jonathan Tegge, the Chief Financial Officer of InMed Pharmaceuticals Inc. (the “Company”), hereby certify that, to my knowledge:


1.The Annual Report on Form 10-K/A for the year ended June 30, 2023 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and


2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: December 21, 2023


/s/ Jonathan Tegge  
Name:  Jonathan Tegge  
Title: Interim Chief Financial Officer